Honz Pharmaceutical Co., Ltd. (SHE:300086)
8.21
-0.22 (-2.61%)
Mar 20, 2026, 3:04 PM CST
Honz Pharmaceutical Revenue
Honz Pharmaceutical had revenue of 93.93M CNY in the quarter ending September 30, 2025, a decrease of -34.59%. This brings the company's revenue in the last twelve months to 435.39M, down -33.19% year-over-year. In the year 2024, Honz Pharmaceutical had annual revenue of 472.82M, down -36.07%.
Revenue (ttm)
435.39M
Revenue Growth
-33.19%
P/S Ratio
8.58
Revenue / Employee
660.68K
Employees
659
Market Cap
3.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 472.82M | -266.75M | -36.07% |
| Dec 31, 2023 | 739.57M | 203.82M | 38.05% |
| Jan 1, 2023 | 535.75M | -300.82M | -35.96% |
| Jan 1, 2022 | 836.57M | -85.08M | -9.23% |
| Dec 31, 2020 | 921.64M | -86.79M | -8.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Huaren Pharmaceutical | 1.26B |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.10B |
| Harbin Medisan Pharmaceutical | 874.60M |
| Shandong Wohua Pharmaceutical | 816.95M |
| Qianjiang Yongan Pharmaceutical | 797.25M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |